about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceThird-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactionsA Long-Term Treatment with Arachidonyl-2'-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of EpilepsyEffects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.[Neuroprotective activity of antiepileptic drugs].Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides.Clinical utility of adjunctive retigabine in partial onset seizures in adults.Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1-[1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl]pyrrolidine-2,5-diones.Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice.Mood disorders in patients with epilepsy.Effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the protective action of various antiepileptic drugs in the maximal electroshock-induced seizure model: a type II isobolographic analysis.Isobolographic analysis demonstrates additive effect of cisplatin and HDIs combined treatment augmenting their anti-cancer activity in lung cancer cell lines.Modulation of adenosinergic system and its application for the treatment of epilepsy.Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.Additive Interaction of Cisplatin and Histone Deacetylase Inhibitors Combined Treatment in Rhabdomyosarcoma Cells - An Isobolographic Analysis.Exploring the latest avenues for antiepileptic drug discovery and development.Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis.Synergistic interaction of gabapentin with tiagabine in the hot-plate test in mice: an isobolographic analysis.Synergistic interaction of gabapentin with tiagabine in the formalin test in mice: an isobolographic analysis.Effects of some new antiepileptic drugs and progabide on glucocorticoid receptor-mediated gene transcription in LMCAT cells.Influence of MPEP (a selective mGluR5 antagonist) on the anticonvulsant action of novel antiepileptic drugs against maximal electroshock-induced seizures in mice.ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs.Seizure susceptibility to electroconvulsions or pentylenetetrazol after complete cerebral ischemia in rats due to cardiac arrest.Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione - a novel anticonvulsant drug candidate.Influence of Ivabradine on the Anticonvulsant Action of Four Classical Antiepileptic Drugs Against Maximal Electroshock-Induced Seizures in Mice.Proconvulsant effects of the ketogenic diet in electroshock-induced seizures in mice.Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer CellsAnticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: a comparative study.Dose-response relationship analysis of pregabalin doses and their antinociceptive effects in hot-plate test in mice.Influence of ethacrynic acid on the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock seizure model.Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.Additive interactions of pregabalin with lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves.Interactions of stiripentol with clobazam and valproate in the mouse maximal electroshock-induced seizure model.Interaction of pregabalin with carbamazepine in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis for non-parallel dose-response relationship curves.Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.[Drug resistance in epilepsy].Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis.
P50
Q26739831-88436F7F-EB26-4E99-B83D-522385988B7FQ28245021-049C13FC-988C-4783-997B-18736BFE4B76Q33754746-6A4041AB-B00C-4D5A-A102-3A8EB48AF6EAQ33785477-9A33C7C4-CA45-420D-891C-BA47F85E7E6FQ34396883-C7959F10-0CDF-4AA3-9A41-362E8C0BBE7CQ35600431-0B2BFBC2-AD91-430F-9740-5639C9036F16Q35656094-D2E51443-8C53-4F8E-9045-393FC676CB47Q35717049-350F62CA-C77B-4EF7-AB39-B4229BC8CCB7Q35781823-11405D5C-88FA-4C0D-8EBE-F13CB7ED25A0Q35845089-83271248-4C5D-411C-B9B7-E9C2586E7121Q35889041-F8ACB58A-9129-4604-BCE0-975785B943C9Q36106513-11D1AB3B-8BFA-4A97-BD2B-439109CE5BA0Q36954211-0C9DA5B2-DF85-471A-BF67-B317ACEAE02DQ37325722-CE2417F8-1A96-4127-BF19-BA760D489514Q37545100-FD8A34FD-0A3C-4BCC-B256-7587254224E8Q38218210-41A23CC8-783F-4F29-B0E4-E6F51EA5B7FEQ38634921-B8120580-7C09-48DD-809E-05400792073CQ38711813-A59E91F3-EE68-4CAD-886E-0B88CC050C59Q38754189-EBA6E272-AE52-4BE7-B92F-F0002BAED583Q39244593-B9BC6D11-BB5A-44C0-8EB7-D48578D2A64EQ39244593-BB25523E-5FC7-4EA1-85D1-387123240DEAQ39300885-6D16F4A8-1CED-4B10-9E35-CE0AC06ACF88Q39314422-47AAA286-E6BB-45F8-9FFD-45160F43D2A8Q40042400-A9F020D2-1C81-454F-8020-19CBE4D4456AQ40418883-195A6C4B-461B-46CC-A704-0B6204A94DBCQ40678192-52D33F2A-938D-40EE-AC2E-79A914A73D29Q40986654-8FB70A20-12B8-4290-B0BF-D1EB084794B8Q41454841-FE4F9CE4-865A-453F-877E-074D266103C3Q42293130-C4511965-1445-433D-AA18-A93991A3E78FQ42317046-03AEFA62-39C0-4591-8D4F-F31E527207A7Q42328146-BD5BDB00-A07C-478A-BB49-ABA80D58E8A8Q42754345-4D3B7AA1-3B59-4A68-A096-5230C405E1DBQ42794505-07B1866C-31F0-4526-885D-22D6F94E7BBBQ42794546-49F108B6-7421-4487-BFBD-C6A42EA15913Q42913488-A5EC4151-AAC3-4A5B-873F-E01D0A3B48C3Q42943801-1D3E9D06-8F91-4553-9335-2E5674B821C9Q43056706-4BBF8730-A41C-4256-8D79-1C97F0ECF757Q43108166-A1D6D069-4F06-48BE-85DC-3CDED62A3CDEQ43111557-378CB0A2-34FC-4760-B4D8-F8C8404DEA85Q43125341-938B6194-570D-4264-BC00-A75018316B66
P50
description
Polish researcher
@en
hulumtues
@sq
onderzoeker
@nl
polski naukowiec
@pl
ricercatore
@it
հետազոտող
@hy
name
Jarogniew J Luszczki
@ast
Jarogniew J Luszczki
@en
Jarogniew J Luszczki
@es
Jarogniew J Luszczki
@nl
Jarogniew J Luszczki
@sl
Jarogniew Jacek Łuszczki
@ca
Jarogniew Jacek Łuszczki
@cs
Jarogniew Jacek Łuszczki
@gl
Jarogniew Jacek Łuszczki
@hr
Jarogniew Jacek Łuszczki
@hsb
type
label
Jarogniew J Luszczki
@ast
Jarogniew J Luszczki
@en
Jarogniew J Luszczki
@es
Jarogniew J Luszczki
@nl
Jarogniew J Luszczki
@sl
Jarogniew Jacek Łuszczki
@ca
Jarogniew Jacek Łuszczki
@cs
Jarogniew Jacek Łuszczki
@gl
Jarogniew Jacek Łuszczki
@hr
Jarogniew Jacek Łuszczki
@hsb
altLabel
Jarogniew Jacek Łuszczki
@en
Jarogniew Łuszczki
@en
Jarogniew Łuszczki
@pl
prefLabel
Jarogniew J Luszczki
@ast
Jarogniew J Luszczki
@en
Jarogniew J Luszczki
@es
Jarogniew J Luszczki
@nl
Jarogniew J Luszczki
@sl
Jarogniew Jacek Łuszczki
@ca
Jarogniew Jacek Łuszczki
@cs
Jarogniew Jacek Łuszczki
@gl
Jarogniew Jacek Łuszczki
@hr
Jarogniew Jacek Łuszczki
@hsb
P214
P106
P1412
P1559
Jarogniew Jacek Łuszczki
@pl
P21
P214
P27
P31
P3124
P496
0000-0002-3059-0393
P7859
viaf-317136796